伪膜性结肠炎和帕拉巴克特罗伊德菌种的细菌病:一种罕见的临床表现
Catherine Hsu1, Claudia Moore-Gillon1, Mathew Vithayathil2,3
1Imperial College Healthcare NHS Trust, London, UK.
Clinical journal of gastroenterology
|March 14, 2024
概括
本案例研究详细介绍了一名患有脏疾病的糖尿病患者,在感染Clostridium difficile后,患有肠道细菌,Parabacteroides distasonis和Enterobacter cloacae的败血症. 这突出了与C. difficile有关的肠道无氧血液感染的罕见案例.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 末期脏病 (ESRD) 患者接受血液透析是免疫受损的.
- 糖尿病病是ESRD的主要原因.
- 患有ESRD的患者患有感染的风险增加,包括Clostridium difficile感染 (CDI).
研究的目的:
- 在患有困难菌体感染的患者中报告第一个Parabacteroides distasonis bacteremia病例.
- 在这种背景下,探索肠道转移导致肠道厌氧生物系统性传播的潜在机制.
- 描述患有糖尿病病,数字和并发性CDI的患者的临床过程和管理.
主要方法:
- 病例报告详细介绍了一个患有末期糖尿病病症的患者.
- 临床表现包括急性-慢性数字,败血症,腹痛和腹.
- 诊断程序包括灵活的半导体镜,血液培养,结肠培养和数字片.
主要成果:
- 灵活的半导体镜检查证实了由Clostridium difficile引起的二次性伪膜性结肠炎.
- 血液培养物确定了Parabacteroides distasonis,一种格兰氏阴性肠道无氧生物.
- 肠杆菌cloacae从结肠培养物和数字拭片中分离出来.
- 患者在接受抗生素治疗后恢复过来.
结论:
- 伪膜性结肠炎可能会增加肠道转位,促进肠道厌氧菌的全身传播.
- 这是与Clostridium difficile感染相关的第一个报告的Parabacteroides distasonis bacteremia病例.
- 成功管理涉及抗生素和随后的血管干预数字.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
181
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
181
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Inflammatory Bowel Disease II: Crohn's Disease
240
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
240
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
160
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
160
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
117
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
117


